… but things may be looking up. Marketplace Podcast, Interview With CEO Wayne Woodard Public media podcast, Marketplace, delves into the intricate responses of manufacturing companies to the challenges posed
In this n-Lorem podcast episode, Bottling Hope, host Stan Crook introduces guest Wayne Woodard, CEO of Argonaut. Wayne details his background in industrial technology, emphasizing the importance of operational roles
In the podcast series Molecule to Market, Raman Sehgal interviews influential leaders in the biopharmaceutical industry. In this recent episode, he talked to Wayne Woodard, Founder and CEO of Argonaut Manufacturing
CARLSBAD, CA March 08, 2023— Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving the biopharma, life science, and molecular diagnostics industries, announced that it has signed drug
As the JPM meeting of 2023 closes, what can we learn from the last year and project into 2023 for biotech/pharma contract manufacturing? Responding to this question is critical. As
Carlsbad, CA, 10th January 2023 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, today announced a capital investment led
Updated October 16, 2022 In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward to late 2022, and the economic conditions wrought by disease, war,
Carlsbad, CA, 7/26/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life sciences, and molecular diagnostics industries, today announced the launch of LyoDots,*TM the world’s
Simplify Molecular Assays with BioFuse Sample Prep Device Carlsbad, CA, 7/25/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life sciences, and molecular diagnostics industries,
Opinion: Wayne Woodard, CEO Argonaut Manufacturing Services In early September 2020, I wrote an opinion piece titled “Bring Manufacturing Back to the USA” that generated quite a bit of controversy.
